
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Revenue | $33.1B | $35.3B | $34.2B | $33.9B | $33.1B | |
Revenue Growth (YoY) | 0.12% | 6.81% | -3.08% | -0.87% | -2.62% | |
Cost of Revenues | $5.3B | $6B | $5.6B | $5.8B | $5.7B | |
Gross Profit | $27.8B | $29.3B | $28.6B | $28.2B | $27.4B | |
Gross Profit Margin | 83.95% | 82.94% | 83.53% | 82.99% | 82.85% | |
R&D Expenses | $155.3M | $194M | $170.9M | $225.2M | $222.4M | |
Selling, General & Admin | $1.4B | $1.7B | $1.5B | $1.5B | $1.5B | |
Other Inc / (Exp) | -- | -- | -- | -- | -- | |
Operating Expenses | $10B | $14.3B | $9.7B | $41.4B | $16B | |
Operating Income | $17.8B | $15B | $18.9B | -$13.2B | $11.4B | |
Net Interest Expenses | $2.3B | $2B | $2B | $2.1B | $2B | |
EBT. Incl. Unusual Items | $11.1B | $12.6B | $11.5B | -$21.2B | $4.5B | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $2.7B | $3B | $3.1B | -$3.6B | $456.3M | |
Net Income to Company | $8.4B | $9.6B | $8.5B | -$17.7B | $4.1B | |
Minority Interest in Earnings | -$210.5M | -$238M | -$222.9M | -$221.5M | -$144.4M | |
Net Income to Common Excl Extra Items | $8.2B | $9.4B | $8.3B | -$17.9B | $3.9B | |
Basic EPS (Cont. Ops) | $3.59 | $4.08 | $3.63 | -$8.05 | $1.75 | |
Diluted EPS (Cont. Ops) | $3.58 | $4.07 | $3.61 | -$8.05 | $1.74 | |
Weighted Average Basic Share | $2.3B | $2.3B | $2.3B | $2.2B | $2.2B | |
Weighted Average Diluted Share | $2.3B | $2.3B | $2.3B | $2.2B | $2.2B | |
EBITDA | $15B | $16.1B | $15.2B | $11B | $10.8B | |
EBIT | $13.4B | $14.7B | $13.6B | -$18.9B | $6.9B | |
Revenue (Reported) | $33.1B | $35.3B | $34.2B | $33.9B | $33.1B | |
Operating Income (Reported) | $17.8B | $15B | $18.9B | -$13.2B | $11.4B | |
Operating Income (Adjusted) | $13.4B | $14.7B | $13.6B | -$18.9B | $6.9B |
Period Ending | 2019-03-31 | 2020-03-31 | 2021-03-31 | 2022-03-31 | 2023-03-31 | |
---|---|---|---|---|---|---|
Revenue | -- | -- | -- | -- | $84.7M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -98.32% | |
Cost of Revenues | -- | -- | -- | -- | -- | |
Gross Profit | -- | -- | -- | -- | -- | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | -- | -- | -- | -- | -- | |
Other Inc / (Exp) | -- | -- | -- | -- | -- | |
Operating Expenses | -- | -- | -- | -- | -- | |
Operating Income | -- | -- | -- | -- | -- | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | -- | -- | -- | -- | -- | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -- | -- | -- | -- | |
Net Income to Company | -- | -- | -- | -- | -- | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -- | -- | -- | -- | -- | |
Basic EPS (Cont. Ops) | -- | -- | -- | -- | -- | |
Diluted EPS (Cont. Ops) | -- | -- | -- | -- | -- | |
Weighted Average Basic Share | -- | -- | -- | -- | -- | |
Weighted Average Diluted Share | -- | -- | -- | -- | -- | |
EBITDA | -- | -- | -- | -- | -- | |
EBIT | -- | -- | -- | -- | -- | |
Revenue (Reported) | -- | -- | -- | -- | $84.7M | |
Operating Income (Reported) | -- | -- | -- | -- | -- | |
Operating Income (Adjusted) | -- | -- | -- | -- | -- |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Revenue | $33B | $35.2B | $33.6B | $34B | $32.9B | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $5.3B | $6B | $5.5B | $5.8B | $5.6B | |
Gross Profit | $27.7B | $29.2B | $28B | $28.2B | $27.2B | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | -- | -- | -- | -- | -- | |
Other Inc / (Exp) | -- | -- | -- | -- | -- | |
Operating Expenses | $9.9B | $14.3B | $9.8B | $41.4B | $15.9B | |
Operating Income | $17.9B | $14.9B | $18.3B | -$13.1B | $11.4B | |
Net Interest Expenses | $2.3B | $2B | $1.9B | $2.1B | $2B | |
EBT. Incl. Unusual Items | $11.1B | $12.6B | $11.2B | -$21.1B | $4.4B | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $2.7B | $3B | $3B | -$3.6B | $437.7M | |
Net Income to Company | $8.3B | $9.6B | $8.2B | -- | -- | |
Minority Interest in Earnings | -$210M | -$237.1M | -$218.1M | -$221.8M | -$143.4M | |
Net Income to Common Excl Extra Items | $8.2B | $9.3B | $8B | -$17.8B | $3.8B | |
Basic EPS (Cont. Ops) | $3.57 | $4.07 | $3.51 | -$8.01 | $1.71 | |
Diluted EPS (Cont. Ops) | $3.56 | $4.06 | $3.50 | -$8.02 | $1.70 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | $15B | $16B | $14.8B | $11B | $10.6B | |
EBIT | $13.4B | $14.6B | $13.2B | -$18.8B | $6.8B | |
Revenue (Reported) | $33B | $35.2B | $33.6B | $34B | $32.9B | |
Operating Income (Reported) | $17.9B | $14.9B | $18.3B | -$13.1B | $11.4B | |
Operating Income (Adjusted) | $13.4B | $14.6B | $13.2B | -$18.8B | $6.8B |
Period Ending | 2021-07-18 | 2022-07-18 | 2023-07-18 | 2024-07-18 | ||
---|---|---|---|---|---|---|
Revenue | -- | -- | -- | -- | -- | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | -- | -- | -- | -- | -- | |
Gross Profit | -- | -- | -- | -- | -- | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | -- | -- | -- | -- | -- | |
Other Inc / (Exp) | -- | -- | -- | -- | -- | |
Operating Expenses | -- | -- | -- | -- | -- | |
Operating Income | -- | -- | -- | -- | -- | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | -- | -- | -- | -- | -- | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -- | -- | -- | -- | |
Net Income to Company | -- | -- | -- | -- | -- | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -- | -- | -- | -- | -- | |
Basic EPS (Cont. Ops) | -- | -- | -- | -- | -- | |
Diluted EPS (Cont. Ops) | -- | -- | -- | -- | -- | |
Weighted Average Basic Share | -- | -- | -- | -- | -- | |
Weighted Average Diluted Share | -- | -- | -- | -- | -- | |
EBITDA | -- | -- | -- | -- | -- | |
EBIT | -- | -- | -- | -- | -- | |
Revenue (Reported) | -- | -- | -- | -- | -- | |
Operating Income (Reported) | -- | -- | -- | -- | -- | |
Operating Income (Adjusted) | -- | -- | -- | -- | -- |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $2.5B | $2B | $2.1B | $3B | $3.6B | |
Short Term Investments | $329.8M | $615.4M | $700.7M | $765.6M | $643.7M | |
Accounts Receivable, Net | $5.1B | $5.3B | $5.3B | $4.6B | $4.5B | |
Inventory | $8.2B | $7.1B | $6.9B | $6.3B | $5.8B | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | -- | -- | -- | -- | -- | |
Total Current Assets | $18.6B | $17.3B | $18.6B | $18.1B | $17.9B | |
Property Plant And Equipment | $6.9B | $6.7B | $5.9B | $5.8B | $5.5B | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | $59B | $58.3B | $58B | $52.3B | $51.6B | |
Other Intangibles | $98.2B | $97.8B | $98.2B | $69.4B | $66.7B | |
Other Long-Term Assets | -- | -- | -- | -- | -- | |
Total Assets | $187.6B | $185.4B | $185.8B | $151.2B | $149.2B | |
Accounts Payable | $13.2B | $12.9B | $12.6B | $12.4B | $12B | |
Accrued Expenses | -- | -- | -- | -- | -- | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | $186.7M | $170.1M | $171.8M | $166.9M | $176.9M | |
Other Current Liabilities | -- | -- | -- | -- | -- | |
Total Current Liabilities | $21.1B | $20.4B | $21.6B | $20B | $23.5B | |
Long-Term Debt | $54B | $47.7B | $46.4B | $44.6B | $40.4B | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $101.9B | $94.4B | $94.2B | $83.8B | $86.5B | |
Common Stock | $836.8M | $828.7M | $743.1M | $782.2M | $734.1M | |
Other Common Equity Adj | -- | -- | -- | -- | -- | |
Common Equity | $85.4B | $90.6B | $91.2B | $67B | $62.3B | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | $384.3M | $404.9M | $413.9M | $468.8M | $441.7M | |
Total Equity | $85.8B | $91B | $91.6B | $67.4B | $62.7B | |
Total Liabilities and Equity | $187.6B | $185.4B | $185.8B | $151.2B | $149.2B | |
Cash and Short Terms | $2.8B | $2.6B | $2.8B | $3.8B | $4.3B | |
Total Debt | $59.3B | $52.9B | $51.6B | $50B | $45.6B |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $2.5B | $2B | $2.1B | $3B | $3.6B | |
Short Term Investments | $329.8M | $615.4M | $700.7M | $765.6M | $643.7M | |
Accounts Receivable, Net | $5.1B | $5.3B | $5.3B | $4.6B | $4.5B | |
Inventory | $8.2B | $7.1B | $6.9B | $6.3B | $5.8B | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | -- | -- | -- | -- | -- | |
Total Current Assets | $18.6B | $17.3B | $18.6B | $18.1B | $17.9B | |
Property Plant And Equipment | $6.9B | $6.7B | $5.9B | $5.8B | $5.5B | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | $59B | $58.3B | $58B | $52.3B | $51.6B | |
Other Intangibles | $98.2B | $97.8B | $98.2B | $69.4B | $66.7B | |
Other Long-Term Assets | -- | -- | -- | -- | -- | |
Total Assets | $187.6B | $185.4B | $185.8B | $151.2B | $149.2B | |
Accounts Payable | $13.2B | $12.9B | $12.6B | $12.4B | $12B | |
Accrued Expenses | -- | -- | -- | -- | -- | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | $186.7M | $170.1M | $171.8M | $166.9M | $176.9M | |
Other Current Liabilities | -- | -- | -- | -- | -- | |
Total Current Liabilities | $21.1B | $20.4B | $21.6B | $20B | $23.5B | |
Long-Term Debt | $54B | $47.7B | $46.4B | $44.6B | $40.4B | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $101.9B | $94.4B | $94.2B | $83.8B | $86.5B | |
Common Stock | $836.8M | $828.7M | $743.1M | $782.2M | $734.1M | |
Other Common Equity Adj | -- | -- | -- | -- | -- | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | $384.3M | $404.9M | $413.9M | $468.8M | $441.7M | |
Total Equity | $85.8B | $91B | $91.6B | $67.4B | $62.7B | |
Total Liabilities and Equity | $187.6B | $185.4B | $185.8B | $151.2B | $149.2B | |
Cash and Short Terms | $2.8B | $2.6B | $2.8B | $3.8B | $4.3B | |
Total Debt | $59.3B | $52.9B | $51.6B | $50B | $45.6B |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $8.4B | $9.6B | $8.5B | -$17.7B | $4.1B | |
Depreciation & Amoritzation | $1.6B | $1.4B | $1.6B | $29.9B | $3.9B | |
Stock-Based Compensation | -- | -- | -- | -- | -- | |
Change in Accounts Receivable | $385M | -$540.7M | -$52M | -$606M | -$343.8M | |
Change in Inventories | -$184.8M | $595.7M | -$304.6M | $329.7M | $44.7M | |
Cash From Operations | $12.6B | $13.4B | $12.9B | $13.3B | $12.9B | |
Capital Expenditures | $969M | $1B | $812.3M | $747.8M | $777M | |
Cash Acquisitions | $50.1M | -$317.8M | -$48.3M | $151.8M | $2B | |
Cash From Investing | -$1B | -$1.6B | -$873M | -$368.3M | $1.8B | |
Dividends Paid (Ex Special Dividend) | -$6.1B | -$6.7B | -$6.1B | -$6.3B | -$6.7B | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $12.6B | $3.7B | $4B | $6.4B | $3.1B | |
Long-Term Debt Repaid | -$13.6B | -$6.7B | -$3.8B | -$8.4B | -$6.2B | |
Repurchase of Common Stock | -$23.1M | -$112.8M | -$2.6B | -$136.9M | -$1B | |
Other Financing Activities | -$338.8M | $320.5M | -$138.7M | -$592.3M | -$157.2M | |
Cash From Financing | -$10.1B | -$12B | -$11B | -$11.6B | -$13.6B | |
Beginning Cash (CF) | $2.6B | $4B | $3.1B | $4.2B | $5.8B | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $1.4B | -$236.6M | $1B | $1.4B | $1.1B | |
Ending Cash (CF) | $3.7B | $3.4B | $4.1B | $5.6B | $6.5B | |
Levered Free Cash Flow | $11.6B | $12.3B | $12.1B | $12.6B | $12.2B |
Period Ending | 2004-12-31 | 2005-12-31 | 2006-12-31 | 2007-12-31 | 2008-12-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $848.2M | $1B | $1.2B | $1.2B | $1.5B | |
Depreciation & Amoritzation | $687.3M | $591.3M | $650.8M | $636.4M | $776.7M | |
Stock-Based Compensation | -- | -- | -- | -- | -- | |
Change in Accounts Receivable | $95.3M | -$323.9M | -$193.6M | -$166.1M | $35.1M | |
Change in Inventories | $82.5M | -$50.9M | $38.7M | $340.2M | -$678.7M | |
Cash From Operations | -$3.6B | $3.3B | $3B | $4B | $5.7B | |
Capital Expenditures | -- | -- | -- | -- | -- | |
Cash Acquisitions | $372.1M | -$218.3M | -$73.7M | $222.1M | -$3.8B | |
Cash From Investing | $88M | -$181.9M | -$106.9M | $322.2M | -$3.8B | |
Dividends Paid (Ex Special Dividend) | -$1.6B | -$1.7B | -$1.9B | -$2.4B | -$2.6B | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | $1.7B | $1.4B | $2.5B | $876.5M | $6.5B | |
Long-Term Debt Repaid | -$2.3B | -$1.6B | -$3.2B | -$854.5M | -$1.4B | |
Repurchase of Common Stock | -$982.4M | -$998.9M | -$1.1B | -$1.6B | -$954.3M | |
Other Financing Activities | $139.3M | -$302M | $5.5M | -$524.3M | -$1.5B | |
Cash From Financing | -$3.1B | -$3.2B | -$3.6B | -$4.5B | $53.6M | |
Beginning Cash (CF) | $6B | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -$6.6B | -$120.1M | -$715.3M | -$192.1M | $1.9B | |
Ending Cash (CF) | -- | $3B | $2.4B | $2.4B | $4.1B | |
Levered Free Cash Flow | -- | -- | -- | -- | -- |
Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $7.5B | $8.3B | $9.6B | $8.2B | -- | |
Depreciation & Amoritzation | $1.9B | $1.6B | $1.4B | $1.6B | -- | |
Stock-Based Compensation | -- | -- | -- | -- | -- | |
Change in Accounts Receivable | -$339M | $425M | -$545.9M | -$46.1M | -- | |
Change in Inventories | -$475.9M | -$144.5M | $553.9M | -$324.8M | -- | |
Cash From Operations | $11.6B | $12.6B | $13.2B | $12.5B | -- | |
Capital Expenditures | $1B | $982.8M | $1B | $783.7M | $164M | |
Cash Acquisitions | -$110.6M | $51.7M | -$317.9M | -$46.3M | -$47.6M | |
Cash From Investing | -$822.6M | -$1B | -$1.6B | -$845.9M | -- | |
Dividends Paid (Ex Special Dividend) | -$5.9B | -$6.1B | -$6.7B | -$6B | -$3.1B | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $5.5B | $12.6B | $3.7B | $4.1B | -- | |
Long-Term Debt Repaid | -$7.3B | -$13.8B | -$6.6B | -$3.7B | -- | |
Repurchase of Common Stock | -$150.4M | -$22.4M | -$114.6M | -$2.6B | -- | |
Other Financing Activities | -$696.7M | -$349M | $305.6M | -$110.9M | -- | |
Cash From Financing | -$11.1B | -$10.3B | -$11.9B | -$10.6B | -- | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -$308.2M | $930.7M | -$200.8M | $924.4M | -- | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | $10.5B | $11.7B | $12.2B | $11.7B | -- |
Period Ending | 2021-07-18 | 2022-07-18 | 2023-07-18 | 2024-07-18 | ||
---|---|---|---|---|---|---|
Net Income to Stockholders | -- | -- | -- | -- | -- | |
Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
Stock-Based Compensation | -- | -- | -- | -- | -- | |
Change in Accounts Receivable | -- | -- | -- | -- | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -- | -- | -- | -- | -- | |
Capital Expenditures | -- | -- | -- | -- | -- | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -- | -- | -- | -- | -- | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -- | -- | -- | -- | |
Cash From Financing | -- | -- | -- | -- | -- | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -- | -- | -- | -- | -- | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | -- | -- | -- | -- | -- |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.